(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Financial Results: Big Lots Reports Q1 Loss, PDD Surpasses Estimates, and LightInTheBox Achieves Record-breaking Quarter

May 26th, 2023

Big Lots, Inc. (NYSE: BIG) has announced its financial results for the first quarter of fiscal 2023, revealing an adjusted loss of $3.40 per share. This result is in contrast to the consensus estimate of a loss of $1.77 per share..  The compa. Read more

Corporate Earnings, Revised Guidance, and Medical Breakthroughs: Insights on Hibbett, Booz Allen Hamilton, and Novo Nordisk

May 26th, 2023

Hibbett, Inc. (Nasdaq: HIBB) released its first-quarter fiscal 2024 earnings per share (EPS) of $2.74, falling short of the consensus estimate of $3.04.  The company revised its full-year fiscal 2024 guidance to reflect a more cautious consum. Read more

Financial Performance and Clinical Updates: 23andMe, RH, and Aravive - Latest Reports and Future Prospects

May 26th, 2023

In the world of financial markets and healthcare, several companies have recently reported their financial performance and provided updates on their ongoing trials and future prospects. Genetic testing company 23andMe Holding Co. (Nasdaq: ME) disc. Read more

Promising Clinical Trial Updates and Earnings Reports Drive Stock Price Movements: PDS Biotechnology, eFFECTOR Therapeutics, Costco, and Gap

May 26th, 2023

PDS Biotechnology Corporation (Nasdaq: PDSB) and eFFECTOR Therapeutics, Inc. (Nasdaq: EFTR) shared promising interim data updates from their respective clinical trials, leading to significant stock price movements in after-hours trading. These develo. Read more

FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults

May 25th, 2023

Silver Spring, MD / CRWE PRESS RELEASE / May 25, 2023  -  Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mil. Read more

Quarterly Earnings Reports: Autodesk, Workday, Marvell Technology, and Ulta Beauty Showcase Financial Performance

May 25th, 2023

In the latest round of quarterly earnings reports, several prominent companies have disclosed their financial performance for the respective fiscal periods. Autodesk, Inc. (Nasdaq: ADSK), a leading software company, has reported its first-quarter . Read more

Significant Upgrades and PT Adjustments by Brokerage Firms: Dycom Industries, Ford, Futu Holdings, NVIDIA, Pembina Pipeline, Toll Brothers, and Vipshop

May 25th, 2023

Brokerage firms have made significant adjustments to their price targets and ratings for several prominent companies. These revisions reflect changing perspectives on the growth prospects and investment potential of these stocks. Dycom Industries,. Read more

Wearable Devices Launches Mudra Band Preorders; Beamr Imaging Soars on NVIDIA's NVENC New Features; Dorian LPG Upgraded

May 25th, 2023

Wearable Devices Ltd. (Nasdaq: WLDS) has officially announced the availability of its flagship consumer product, the Mudra Band for Apple Watch, for preorder. This marks an exciting milestone for the company as it prepares for its first volume manufa. Read more

Analysts Bullish on SentinelOne, Mobileye Global, Carnival, Leidos Holdings and RenaissanceRe

May 25th, 2023

Raymond James has initiated coverage of SentinelOne, Inc. (NYSE: S) with a Strong Buy rating and set a price target of $25. During pre-market, $S is currently trading at $20.50, displaying an upward trend of $0.62 (+3.12%). Wells Fargo has init. Read more

Best Buy Beats Estimates, GDS Holdings Surprises with Narrowed-Than-Expected Loss, Nano Dimension's Bold Offer to Increase Stake in Stratasys

May 25th, 2023

Best Buy Co., Inc. (NYSE: BBY) has announced its financial results for the first quarter of fiscal year 2024, reporting earnings per share (EPS) of $1.15. This figure surpasses the consensus estimate of $1.11 per share. The company's sales perfor. Read more